{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04357717",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ECT2018-001"
      },
      "Organization": {
        "OrgFullName": "Exosome Diagnostics, Inc.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting",
      "OfficialTitle": "Clinical Evaluation of ExoDxâ„¢ Prostate (IntelliScore) in Men With Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 15, 2020",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 20, 2020",
      "StudyFirstSubmitQCDate": "April 21, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 22, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 29, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 30, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Exosome Diagnostics, Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The study is designed to confirm the performance of the ExoDx Prostate test in prior negative biopsy patients now presenting for a repeat prostate biopsy.\n\nNote: ExoDx Prostate test results are collected for correlation to biopsy results and are not disclosed to the physician or study subject.",
      "DetailedDescription": "Primary Endpoint:\n\nEvaluate the correlation of the ExoDx Prostate test results with the outcome of prostate biopsies in a prior negative repeat biopsy patient cohort.\n\nSecondary Endpoints (exploratory):\n\nEvaluate the clinical performance of the ExoDx Prostate test at the cut-point of 15.6 defined for the initial biopsy patient cohort.\nAssociate ExoDx Prostate test results with other ancillary studies including the use of radiographic imaging (e.g. multiparametric MRI).\nEvaluate the correlation of ExoDx Prostate as a function of risk. It is known that a higher ExoDx Prostate score correlates to a higher risk of finding prostate cancer, including HGPC, upon biopsy.\nEvaluate ExoDx Prostate with and without inclusion of standard of care parameters such as PSA, ethnicity, DRE, age and family history."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Prostate Cancer"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "exosome",
          "ExoDx Prostate"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Cohort"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "350",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Diagnostic Test",
            "InterventionName": "ExoDx Prostate",
            "InterventionDescription": "Urine-based biomarker tool to support decision to biopsy in patients with PSA between 2-10ng/ml"
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Correlation of the ExoDx Prostate test results with the outcome of prostate biopsies in a prior negative repeat biopsy patient cohort.",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\n50+ years of age\nClinical suspicion for prostate cancer\nElevated Prostate-specific Antigen between 2.0-10 ng/ mL\nAt least one (1) prior negative prostate biopsy\n\nExclusion Criteria:\n\nUse of medications or hormones that are known to affect serum PSA levels within 3-6 months of study enrollment including 5-alpha-reductase inhibitors used in the treatment of an enlarged prostate gland (benign prostatic hyperplasia). Drugs in this class are finasteride (Proscar, Propecia) and dutasteride (Avodart).\nClinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.\nHistory of prostate cancer.\nHistory of invasive treatments for benign prostatic hypertrophy (BPH) or lower urinary track symptoms within 6 months of study enrollment.\nNo known hepatitis status (all types) and/or HIV documented in patient's medical record.\nPatients with history of concurrent renal/bladder tumors.",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "Male",
      "GenderBased": "Yes",
      "GenderDescription": "Male",
      "MinimumAge": "50 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Men, aged 50yrs or older with an elevated PSA between 2-10ng/ml and at least one prior negative prostate biopsy",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Sonia Kumar, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "6175880500",
            "CentralContactEMail": "Sonia.Kumar@bio-techne.com"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Chesapeake Urology Research Associates",
            "LocationStatus": "Recruiting",
            "LocationCity": "Baltimore",
            "LocationState": "Maryland",
            "LocationZip": "21204",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Angela Somers",
                  "LocationContactRole": "Contact"
                }
              ]
            }
          },
          {
            "LocationFacility": "New Jersey Urology",
            "LocationStatus": "Recruiting",
            "LocationCity": "Voorhees",
            "LocationState": "New Jersey",
            "LocationZip": "08043",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Jennifer Pilallis",
                  "LocationContactRole": "Contact"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000011471",
            "ConditionMeshTerm": "Prostatic Neoplasms"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000005834",
            "ConditionAncestorTerm": "Genital Neoplasms, Male"
          },
          {
            "ConditionAncestorId": "D000014565",
            "ConditionAncestorTerm": "Urogenital Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000011469",
            "ConditionAncestorTerm": "Prostatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M13487",
            "ConditionBrowseLeafName": "Prostatic Neoplasms",
            "ConditionBrowseLeafAsFound": "Prostate Cancer",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8098",
            "ConditionBrowseLeafName": "Genital Neoplasms, Male",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16467",
            "ConditionBrowseLeafName": "Urogenital Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13485",
            "ConditionBrowseLeafName": "Prostatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}